SCHEMBL7339386

SCHEMBL7339386

CNC(=O)Nc1ccccc1C(=O)OC

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.69
KDM4E B2RXH2 11/20 0.68
POLB P06746 1/20 0.68
ATM Q13315 1/20 0.68
KMT2A Q03164 2/20 0.67
ALDH1A1 P00352 7/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
RECQL P46063 1/20 0.66
HPGD P15428 2/20 0.63
HSD17B10 Q99714 4/20 0.61
MAPT P10636 2/20 0.61
MEN1 O00255 1/20 0.61
USP2 O75604 1/20 0.61
ALOX15 P16050 1/20 0.61
TSHR P16473 2/20 0.59
MAPK1 P28482 1/20 0.59
HTT P42858 2/20 0.58
LMNA P02545 1/20 0.58
TDP1 Q9NUW8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Anthranilate SCHEMBL7332817 0.91 ALDH1A1 (0.68) GAAKDM4EPOLBATMKMT2A
SCHEMBL30826510 0.86 GAA (0.69) GAAKDM4EPOLBATMKMT2A
SCHEMBL13936399 0.83 KMT2A (0.73) GAAKDM4EPOLBATMKMT2A
SCHEMBL16127722 0.83 KDM4E (0.70) GAAKDM4EPOLBATMKMT2A
SCHEMBL16127717 0.83 KDM4E (0.72) GAAKDM4EPOLBATMKMT2A
SCHEMBL10827700 0.83 LMNA (0.72) GAAKDM4EPOLBATMKMT2A
SCHEMBL10165944 0.81 KMT2A (0.71) GAAKDM4EPOLBATMKMT2A
SCHEMBL12049669 0.81 SMN1; SMN2 (0.70) GAAKDM4EPOLBKMT2AALDH1A1
SCHEMBL1640485 0.81 KMT2A (0.71) GAAKDM4EPOLBATMKMT2A
SCHEMBL4341926 0.81 KMT2A (0.71) GAAKDM4EPOLBATMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629468-B2 Neuroprotectants, analgesics or anticonvulsants JANSSEN PHARMACEUTICA NV (BE) 2009-12-08 US disclosed
US-7629468-B2 Neuroprotectants, analgesics or anticonvulsants JANSSEN PHARMACEUTICA NV (BE) 2009-12-08 US disclosed
US-7517517-B2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-14 US disclosed
US-7517517-B2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-14 US disclosed
WO-2003082350-A2 RADIOLABELLED QUINOLINE AND QUINOLINONE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS JANSSEN PHARMACEUTICA N.V. (BE) 2003-10-09 WO disclosed
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US disclosed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO disclosed
EP-0147211-B1 4H-3,1-BENZOXAZIN-4-ONES AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION SYNTEX (U.S.A.) INC. (US) 1990-09-12 EP disclosed
US-4657893-A ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) INC. (US) 1987-04-14 US disclosed
EP-0147211-A2 4H-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation SYNTEX (U.S.A.) INC. (US) 1985-07-03 EP disclosed